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ABSTRACT
The protein Ocr (overcome classical restriction) from
bacteriophage T7 acts as a mimic of DNA and inhibits
all Type I restriction/modification (RM) enzymes. Ocr
is a homodimer of 116 amino acids and adopts an
elongated structure that resembles the shape of a
bent 24 bp DNA molecule. Each monomer includes 34
acidic residues and only six basic residues. We have
delineated the mimicry of Ocr by focusing on the
electrostatic contribution of its negatively charged
amino acids using directed evolution of a synthetic
form of Ocr, termed pocr, in which all of the 34 acidic
residues were substituted for a neutral amino acid.
In vivo analyses confirmed that pocr did not display
any antirestriction activity. Here, we have subjected
the gene encoding pocr to several rounds of di-
rected evolution in which codons for the correspond-
ing acidic residues found in Ocr were specifically
re-introduced. An in vivo selection assay was used
to detect antirestriction activity after each round of
mutation. Our results demonstrate the variation in
importance of the acidic residues in regions of Ocr
corresponding to different parts of the DNA target
which it is mimicking and for the avoidance of dele-
terious effects on the growth of the host.
INTRODUCTION
Nature is replete with examples of mimicry, both at the
macro and molecular level. Phage- or plasmid-encoded an-
tirestriction proteins that act as structural mimics of DNA
alleviate the effects of host restriction during invasion of the
host by phage or plasmid DNA (1–6). To date, the bacte-
riophage T7 protein Ocr is probably the best characterised
structural mimic of double stranded DNA (7–18). Ocr is
able to competitively inhibit Type I restriction modification
(RM) systems found in eubacteria.
Type I RM systems are complex oligomeric multifunc-
tional enzymes that can mediate both restriction and mod-
ification of a DNA substrate (19–22). Recent analyses have
confirmed that Type I RM systems are widely found in di-
verse eubacteria and provide a formidable barrier to the ex-
change of DNA by horizontal gene transfer or phage in-
fection (23). The Type I RM system operates by modifying
the host DNA viamethylation of specific bases at an asym-
metric bipartite recognition sequence containing a central
non-specific spacer region which marks it as being ‘self ’
(24). For example, the EcoKI Type I RM enzyme recog-
nises 5′-AACNNNNNNGTGC-3′ within a larger footprint
and determines the methylation status of the adenine at the
underlined bases (25,26). DNA entering the cell (e.g. dur-
ing phage infection) that lacks the appropriate pattern of
modification will be recognised as ‘foreign’ and rendered a
target for degradation by the endonuclease component of
the Type I RM system. The Type I RM enzyme comprises
three different subunits, S, M and R, encoded by three dis-
crete genes, hsdS, hsdM and hsdR, respectively. Depend-
ing on the methylation status of the DNA substrate, the
RM complex functions as either a restriction endonuclease
or a methyltransferase. Specifically, the M2S1 complex acts
as a sequence-specificmethyltransferase on hemimethylated
DNA, whereas the complete enzyme, R2M2S1, displays en-
donuclease activity on unmethylated DNA (27–29). The S
subunit identifies the DNA recognition sequence, the two
M subunits contain the methyltransferase activity and the
two R subunits house the ATP-dependent translocase and
endonuclease activity. S-adenosylmethionine (SAM) is the
methyl donor for the methyltransferase activity, whilst the
endonuclease activity requires ATP, SAM and Mg2+.
Bacteriophage T7 gene 0.3, which encodes Ocr, is the
first phage gene to be expressed during the infection of Es-
cherichia coli (1,2). The newly produced Ocr then binds, al-
most irreversibly, to the Type I RM system and protects
the unmodified phage DNA as it enters the host cell by in-
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hibiting the endonuclease activity (7). The structure of Ocr
reveals the protein to be a remarkable mimic of bent B-
form DNA approximately 24-bp in length (8,9,11). Ocr is
a homodimer of a polypeptide of 116 amino acids which
includes an overabundance of acidic residues (30,31). The
structure features several alpha helices and loops (Figure
1a). The overall shape of the protein resembles that of a
bent DNA duplex (∼34◦ in the helical axis) and the nu-
merous surface-exposed carboxylic acid groups are thought
to mimic the phosphate backbone of the DNA molecule
(10,11). Furthermore, the acidic sidechains can be divided
into regions corresponding to the regions of DNA target se-
quence recognised by the Type I RM enzyme (15), namely
a central region corresponding to the non-specific central
part of the target sequence (coloured orange in Figure
1b) flanked by two regions corresponding to the sequence-
specific parts of the target sequence (coloured green in Fig-
ure 1b) and outermost are two regions corresponding to
non-specific DNA making up the remainder of the large
footprint of the RM enzyme (coloured purple in Figure 1b).
The bent shape of Ocr is believed to simulate the bend in-
duced in theDNA substrate upon binding to the Type I RM
enzyme (32). In this way, the ‘pre-bent’ Ocr molecule is en-
ergetically more favoured as a binding partner to the Type
I RM enzyme than an unbent DNA molecule. Hence, the
overall binding affinity of the Type I RM system EcoKI
for Ocr is approximately 50-fold greater than for DNA
(7,8,10,16–18). Thus, a combination of the shape compo-
nent together with the electrostatic mimicry facilitates the
efficient inhibition of the Type I RM system. Although Ocr
is a highly effective mimic of DNA, the mimicry is not se-
quence specific (3,7,11). Hence, Ocr is able to inhibit all
Type I RM systems, rather than one particular enzyme.
We previously investigated the electrostatic component
of the mimicry displayed by Ocr. Initially, we attempted
to analyse the electrostatic contribution of the mimicry by
chemically modifying Ocr to neutralise the surface exposed
carboxylates whilst simultaneously retaining the overall
structure of the protein (13). We found that Ocr requires
a minimum of ∼16 acidic residues per monomer to act as
an effective antirestriction protein. However, the chemical
modification procedure is essentially a random process in
which surface exposed carboxylates are subject to neutral-
isation. As such, the positional context of acidic residues
withinOcr that are particularly important for its interaction
withM.EcoKI (theM2S1 core of theRMenzyme) could not
be established using this approach.
Following the chemical modification experiments, we
substituted acidic residues for neutral amino acids in spe-
cific structural regions of Ocr using site-directed mutage-
nesis (14,15). Mutagenesis of up to 17 amino acids per
monomer resulted in no significant alteration in the protein
fold as based on CD analysis and structural stability stud-
ies. Examination of these mutant proteins, both in vitro and
in vivo, indicated that acidic residues located in the central
loop region (loop 2) of Ocr are particularly important in
terms of its interaction with the archetypal Type I RM sys-
tem EcoKI (Figure 1). However, these mutagenesis studies
were obviously limited to analysing a relatively small num-
ber of mutated forms of Ocr. We therefore sought an inde-
pendent method to identify acidic residues of Ocr that are
principally involved in its DNA mimicry.
During the course of the mutagenesis studies (15) we gen-
erated a mutant form of Ocr, termed pocr, in which all 34
acidic residues had been substituted for the corresponding
isogenic neutral amino acid (i.e. Asp to Asn and Glu to
Gln). The pocr gene was then engineered for heterologous
expression in Escherichia coli. However, despite numerous
attempts, we were unable to detect the accumulation of re-
combinant pocr, suggesting the protein is unable to prop-
erly fold and/or is inherently unstable. Moreover, phage re-
striction assays showed pocr to display no detectable an-
tirestriction activity. These finding were unsurprising given
that pocr comprises a mutation frequency of almost 30%
of the residues found in Ocr. Nonetheless, we reasoned that
the gene encoding pocr could act as an appropriate starting
point for a directed evolution study aimed at generating an
Ocr-like protein with antirestriction activity.
The directed evolution study described in this paper was
designed to introduce codons for acidic amino acids into
appropriate sites in the pocr gene in order to specifically
substitute neutral residues found in pocr for acidic residues
found in Ocr (i.e. Asn to Asp; Gln to Glu as required).
Conditions were chosen to mutate four or five codons per
round of mutation in a random unbiased manner. This pro-
cess can be viewed as a progressive substitution of neutral
residues in pocr, which displays no antirestriction activity,
towards the generation of Ocr, which obviously possesses
antirestriction activity. By subjecting libraries of such pocr
mutants to a powerful plate-based selection procedure after
each round of mutagenesis we hoped to identify an Ocr-like
protein with antirestriction activity containing a much re-
duced number of acidic residues.
MATERIALS AND METHODS
Materials
Unless otherwise stated all the chemicals used in this
study were purchased from Sigma-Aldrich (St Louis, MO,
USA). pBRsk1 (33) is an engineered version of pBR322
(4361 bp) in which one of the two EcoKI sites (4024–
4036) has been removed by site-directed mutagenesis. Plas-
mid pET24a was purchased from Novagen (Madison, WI,
USA) and pTrc99A was a gift from Dr Angela Dawson
(School of Physics and Astronomy, University of Edin-
burgh). A synthetic version of the gene encoding Ocr in
which all the codons for acidic acid residues had been
mutated to codons for the corresponding isogenic neu-
tral residues (Asp and Glu to Asn and Gln, respectively),
termed pocr, was created by GeneArt (Regensberg, Ger-
many). Codon usage was optimised for E. coli (Supplemen-
tary Figure S1). E. coliXL1 Blue supercompetent cells were
obtained from Stratagene (La Jolla, CA, USA) and E. coli
BL21(DE3) was from Invitrogen Life Technologies (Carls-
bad, CA, USA). E. coli NM1261 (r−m−; no RM system)
andE. coliNM1049 (r+m+; EcoKIRM system) were a kind
gift of Professor Noreen Murray (School of Biology, Uni-
versity of Edinburgh,UK). These twoNMstrains were con-
verted to DE3 lysogens as described in (6). E. coliNM1041
(E. coliMG1655 r+m+; EcoKI RM system clpX::kan) and
E. coli NM1057 (E. coli MG1655 rm+; no RM system,
Nucleic Acids Research, 2016, Vol. 44, No. 9 4291
Figure 1. (A) The structure of the dimeric Ocr protein (PDB 1S7Z) showing the alpha helices (A in green, B in magenta, C in blue and D in black), Loop 1
(cyan) and Loop 2 (red). TheN termini of the monomers are at the dimer interface and the C termini at the outer edges of the dimer. (B) The structure of the
Ocr dimer highlighting the acidic amino acids overlapping with different regions of the DNA target recognised by Type I RM enzymes. The orange region
overlaps with the central non-specific region, green overlaps with the two specific parts of the target sequence and purple overlaps with DNA flanking the
target sequence.
hsdREcoKI, clpX::kan) were kind gifts from Dr Angela
Dawson. Virulent unmodified bacteriophage lambda v.o,
or EcoKI-modified lambda v.k were kindly provided by
Professor NoreenMurray. Isoelectric point, pI, values were
calculated using the ExPaSy compute pI/Mw tool in the
bioinformatics research portal.
Library construction
Standard DNA manipulation procedures were used
throughout (34). Directed evolution of pocr was performed
using a modified version of the ISOR protocol described by
Herman and Tawfik (35,36). The libraries were constructed
with desalted oligonucleotides obtained from Invitrogen
(Paisley, UK). Initially, the pocr gene ligated into pET24b
was amplified with oligonucleotides that primed from
within the vector to give a PCR product of 500 bp. The
resulting flanking regions of the PCR product covering part
of the vector sequence facilitated manipulation of the rela-
tively short pocr gene and assisted in the PCR reassembly
step. DNase I digestion of the PCR product was conducted
and the mixture was resolved on a 2% agarose gel before
extracting fragments of <100 bp in length. Mutagenic
oligonucleotides were designed to mutate codons for
neutral amino acids in pocr to the corresponding codons
for acidic residues found in Ocr (i.e. Asn to Asp; Gln to
Glu). To circumvent problems associated with overlapping
mutagenic oligonucleotides, the ISOR procedure was
conducted in four separate reactions targeting four discrete
sets of non-contiguous codons. In order to achieve an
average mutation frequency of four or five mutated codons
per round of ISOR, the total concentration of mutagenic
oligonucleotides was fixed at 200 nM. Equimolar amounts
of each oligonucleotide were used throughout. The se-
quences of the four pools of mutagenic oligonucleotide
primers used in this study are shown in Supplementary
Table S1. The four pools of DNA obtained by ISOR were
then shuffled by DNase I digestion and PCR reassembly
to generate the library for screening. Primers Nfor, 5′-
GTATCACCATGGCTATGTCTAACATG-3′ and Nrev
5′-GATCCCCCGTCAAGCTTA-3′ were designed to
amplify the assembled pocr library and introduce NcoI
and HindIII restriction sites (underlined) in a nested PCR
reaction to facilitate insertion of the DNA into pTrc99A.
In all, three rounds of directed evolution were per-
formed. For the final round of ISOR, degenerate oligonu-
cleotides incorporating more than one mutation were also
used. This step was necessary because the shuffling proce-
dure was inefficient and led to under-representation in the
number of consecutively mutated codons. Consequently, a
bias emerged in the library after the second round that
favoured mutations which were well separated from each
another. Unfortunately, selecting shorter DNA fragments
after DNase I digestion in the shuffling procedure made the
PCR reassembly inefficient. To circumvent such problems,
the third round of mutation included degenerate oligonu-
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cleotides covering successivemutation sites (Supplementary
Table S2). Using this strategy, a degree of randomness in the
construction of the librarywasmaintained. Therewas, how-
ever, a marked reduction in the fidelity of library construc-
tion in terms of the number of unwanted alterations dur-
ing this round of directed evolution. Specifically, we noticed
that ∼10% of the library after the third round of directed
evolution was made up of pocr constructs containing ei-
ther deletions or frameshifts. It is unclear why the introduc-
tion of oligonucleotides containingmore than onemutation
should result in this reduced fidelity, although it may be re-
lated to mispriming events. Nonetheless, we judged that the
library was sufficiently diverse to proceed with the selection
assay.
Selection assay procedure
Each plasmid library was initially used to transform XL-
Gold Supercompetent cells at high efficiency by following
the manufacturer’s instructions (Stratagene). The complete
transformation mix was plated to ensure the diversity of
the respective library was fully represented. The resulting
colonies from all of the plates were pooled using 3 ml of LB
per plate and the plasmid DNA library was prepared using
a Qiagen Maxiprep kit (Qiagen, Hilden, Germany). Each
library was quantified using a ND1000 nanodrop spec-
trophotometer (Thermo Scientific, Waltham, MA, USA).
The plasmid library (1 or 4 ng) was then used to transform
E. coli NM1041 cells. Quenching experiments were carried
out by plating known amounts ofE. coliNM1041 cells with
increasing concentrations of 2-aminopurine (2AP). A 2AP
concentration of 80 g/ml was found to be effective for se-
lecting 2000 colonies of E. coli NM1041 cells per plate (90
mmdiameter Petri dish). Therefore 100 ng of plasmidDNA
was used to transform 200 l of E. coli NM1041 chemi-
cally competent cells and 100 l aliquot (∼2000 colonies)
of the transformation mix was spread on each plate. To
analyse 1.2 × 106 clones for each library, the selection pro-
cess was split into three batches. For each batch, 20 sep-
arate transformations of E. coli NM1041 with the plas-
mid DNA library were plated onto LB-agar plates supple-
mented with 2AP (80 g/ml) and incubated overnight at
37◦C. The plates were then then left at room temperature for
three days. Positive clones from the initial selection screen
were re-streaked onto 2AP-containing plates (80g/ml) for
a second screen. After overnight incubation at 37◦C, any
positive clones were picked and plasmid DNA prepared.
The plasmid was used to transform E. coli NM1041 which
were selected for 2AP resistance as before.Mutated versions
of pocr isolated from the 2AP-resistant cells were subse-
quently sequenced (Genepool, Edinburgh University, Ed-
inburgh, UK).
In vivo phage restriction and modification assay
The activity of the selected pocr mutants was assessed using
an in vivo assay with virulent bacteriophage λv.o or λv.k as
described previously (5).
Protein purification
Recombinant protein was obtained using E. coli
BL21(DE3) as host and purified as described previ-
ously (13,14). M.EcoKI and EcoKI were prepared as
previously described (27,37). All pocr and Ocr protein
concentrations refer to the dimeric form of the protein.
Glutaraldehyde crosslinking
Chemical crosslinking was used to assess whether each of
the pocr mutant proteins exist as a homodimer in solution.
A 25 g aliquot of each protein was processed using the
method described in (15).
Circular dichroism for assessment of pocr folding
Far UV (190–260 nm) circular dichroism (CD) analysis
was performed on a Jasco model J-180 spectropolorime-
ter (Jasco Corporation, Tokyo, Japan) at 25◦C in 10 mM
sodium phosphate buffer pH 8.0, containing 50 mM NaF
and 7mMmercaptoethanol at a protein concentration of 30
M using a 1 mm pathlength cell. Spectra were corrected
for buffer contribution. Each spectrum was an accumula-
tion of four individual scans.
Thermal denaturation
The transition melting temperature Tm of the protein was
measured by a thermal denaturation assay. The assay mea-
sures the fluorescence emitted by the dye SYPRO or-
ange (Invitrogen, Burlington, Canada), which is strongly
quenched in an aqueous environment. The SYPRO orange
(5000-fold dilution of stock provided by Invitrogen) was
added to the protein samples in 10 mM HEPES buffer, pH
8.0 and the temperature was controlled using a qPCR ma-
chine.
Isothermal titration calorimetry
The binding of selected pocr mutants to M.EcoKI was
assessed by isothermal titration calorimetry (ITC) as de-
scribed in (15) but with the substitution of 20 mM HEPES
buffer, pH 7.0.
In vitro DNA cleavage assay
The ability of each pocr mutant to inhibit the endonuclease
activity of EcoKI was assessed in vitro as described in (15)
with the substitution of 10 mM HEPES buffer, pH 7.0 and
the use of 5:1 and 10:1 ratios of pocr mutant to EcoKI and
a reaction time of 10 minutes.
Microscopy and bacterial growth curve experiments
These experiments were performed as described in (15).
Growth curves were determined using hsdR− and hsdR+
strains E. coli NM1261 and E. coli NM1041.
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Figure 2. Endonuclease assay to analyse the inhibition of EcoKI nuclease activity by the pocr mutants. Unmethylated pBRsk1 was digested with EcoKI
to give a linear species of ∼4.4 kb. The experiment was also repeated using EcoKI that had been preincubated with either Ocr or a pocr mutant prior to
the reaction. In each case the reactions were performed in duplicate. The ratio of EcoKI to Ocr or pocr was either 1:5 (top gel) or 1:10 (bottom gel). The
reaction products were resolved on a 0.9% agarose gel. Size marker; 1 kbp ladder (NEB).
RESULTS
Directed evolution of pocr
We aimed to progressively mutate all 34 targeted codons of
the pocr gene in an unbiased manner. To achieve this objec-
tive, we employed a modified version of the ISOR method-
ology (35,36) in which codons for acidic residues replaced
codons for neutral amino acids in a stepwise fashion to gen-
erate a series of libraries. ISOR is a DNA shuffling tech-
nique, which generatesmutations by assembly of the gene of
interest using oligonucleotides containing the desiredmuta-
tion at the appropriate position. In general, conditions were
chosen that favoured the introduction of an average of four
or fivemutated codons for each round of directed evolution.
To the best of our knowledge, ISOR has not previously
been used tomutate small genes, such as pocr, where the tar-
geted sites for mutation are often in close proximity to one
another. As far as possible,mutagenic oligonucleotides were
designed with a similar melting temperature (Tm) and GC
content in order to reduce bias during the assembly process.
For each round ofmutation, separatemutagenesis reactions
were carried out in which four different sets of codons were
independently targeted (Supplementary Figure S2 and Sup-
plementary Table S1). Using this strategy, codons in close
proximity to one another could be mutated without the mu-
tagenic oligonucleotides overlapping. Herman and Tawfik
(35) reported that the mutation frequency in this procedure
could be enhanced by increasing the concentration of muta-
genic oligonucleotides. In our experiments, a desired muta-
tion rate of approx. four to six mutations per round of mu-
tagenesis was achieved using an oligonucleotide concentra-
tion of 200 nM (oligonucleotide concentrations ≥360 nM
inhibited the reaction). To reduce the possibility of intro-
ducing bias, an equimolar amount of each oligonucleotide
was used in all cases.
The mutations introduced in each of the four separate
reactions produced four sub-libraries, which were subse-
quently mixed and shuffled by DNase I digestion followed
by PCR reassembly. Analysis of the resulting library deter-
mined whether the shuffling process was efficient. A total of
30 clones were randomly picked from the library and plas-
mid DNA was prepared from each and sequenced in order
to monitor the average number of introduced mutations. In
this way, wewere able to assess the overall fidelity of the pro-
cedure. Our analysis suggested an average of five mutations
were generated during the first round of mutation with no
clones containing undesired changes (e.g. non-targeted mu-
tations, frameshifts, truncations, duplications, etc.). A small
proportion (∼1–3%) of the library was made up of plas-
mid with no insert (empty vector). This was not deemed to
be a problem because empty vector was lost from the pro-
cess during the subsequent amplification of the pocr insert
prior to the next round of mutagenesis. The shuffled library
was then subjected to the first round of the selection proce-
dure. A plate-based assay was used to screen approximately
1.2 × 106 clones from the first library. No clones displaying
antirestriction activity were detected using this initial selec-
tion process. Therefore, totalDNA from the first librarywas
pooled and subjected to further rounds of ISOR mutagen-
esis followed by selection.
In all, three rounds of mutation using the ISOR proce-
dure were required before the appearance of clones with de-
tectable antirestriction activity. Sequence analysis of the sec-
ond and third round libraries showed the average number of
mutated codons was 6–13 and 8–17, respectively. Approxi-
mately 1.2 × 106 variants from each library were screened
after each successive round of directed evolution.
Selection process
For screening, the library was ligated into the NcoI and
HindIII sites of the pTrc99A vector and the ligation mix
was used to transform E. coli NM1041. This strain has
a functioning Type I RM system (EcoKI) but lacks the
ClpXP protease, which destroys the R subunit of EcoKI
when DNA damaging agents are present. As such, the E.
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coli NM1041 strain is exquisitely sensitive to the presence
of 2AP, which is both an adenine analogue and a powerful
mutagen. When 2AP is present, unmodified sites occur on
the host chromosome and EcoKI cleaves the chromosome.
As such, E. coli NM1041 plated on solid medium contain-
ing 2AP at a concentration of >20 g/ml will not survive.
However, the cells are able to grow if the strain harbours an
inhibitor of the restriction endonuclease, such as Ocr.
Thus, the selection process involved plating out theE. coli
NM1041 transformedwith the library of pocrmutants onto
solid LBmedium supplementedwith 50g/ml carbenicillin
and 80 g/ml 2AP. The presence of a pocr mutant that can
act as an effectiveDNAmimic will inhibit the restriction en-
donuclease and enable survival. Any clones that grew were
picked and then subjected to a second round of screening
using 2AP.
No positive clones were isolated from the first or sec-
ond rounds of directed evolution. However, the third round
of screening generated seven positive clones (M1.1, M1.4,
M1.7, M1.9, M2.1, M2.8 and M2.11). The clones were ver-
ified by retransformation of E. coli NM1041 with the iso-
lated plasmids and then selection using plates supplemented
with 2AP. PlasmidDNAwas isolated from each of the seven
positive clones and the insert was sequenced. Clones M1.7
and M1.9 were found to be identical to each other as were
clones M1.4, M2.1 and M2.11. Thus, our analysis revealed
four of the seven clones contained unique sequences. In
all four cases, mutations of pocr were confined to the tar-
geted codons with no other unanticipated changes. More-
over, each of the introduced point mutations resulted in a
Glu for Gln or Asp for Asn substitution and the total num-
ber of mutations in the four isolated clones were 16, 16, 14
and 17 for M2.1, M1.1, M1.9 and M2.8, respectively.
In vivo phage restriction assay
The activity of the selected pocr mutants was assessed in
vivo using a restriction assay (Table 1). Infection was car-
ried out with v.o of two different E. coli strains, trans-
formed with pTrc99A or the plasmids expressing the pocr
mutants or Ocr as a control.E. coliNM1049(DE3) contains
the EcoKI RM system (r+m+) while E. coliNM1261(DE3)
lacks the RM system (r−m−). The efficiency of plating (eop)
of v.o on E. coli NM1049(DE3) pTrc99A compared to E.
coli NM1261(DE3) pTrc99A was 5 × 10−5 indicating that
EcoKI was active. Comparing the two strains when trans-
formed with the plasmid expressing the wild-type Ocr gave
a similar number of plaques and an eop of 4, demonstrat-
ing that Ocr had inhibited the Type I RM system as antici-
pated. Assaying the four selected pocr mutants in the same
way showed that all were fully active with an eop ranging
from 1 to 3. Control experiments using λv.k showed there
was no cut back in the number of plaques on the restrictive
versus the non-restrictive strain.
In vivo phage modification assay
To assess the methylation activity of each of the mutants,
a phage modification assay was carried out. v.o was used
to infect the modifying host E. coli NM1057 (r−m+) trans-
formed with either pTrc99A or with pTrc99A expressing
Ocr or the selected pocr mutants. E. coliNM1057 expresses
M.EcoKI so phages recovered from a single plaque after
infection should have been methylated by the action of
M.EcoKI unless the pocr mutants successfully inhibited the
methyltransferase activity. Activity was assessed by deter-
mining the eop of the phages recovered from a single plaque
on E. coliNM1057. The eop was determined on the restric-
tive hostE. coliNM1041 (r+m+, clpX−) relative to themod-
ifying host E. coli NM1057 (r−m+, clpX−). If the pocr mu-
tant displays antimodification activity similar to Ocr then
the titre of recovered phages per ml after plating v.o on
E. coli NM1041 would be lower than the titre on E. coli
NM1057. The results showed that wild-type Ocr and all of
the selected pocr mutants were active in preventing DNA
modification by M.EcoKI as their eop was 1 × 10−4 to 3 ×
10−4 (Table 1).
Protein purification
All four of the unique pocr clones selected from the third
round of mutation gave similar levels of expression, equiv-
alent to that observed for wild-type Ocr and were pu-
rified to apparent homogeneity using the same protocol
employed for the purification of wild-type Ocr (data not
shown, 13,14).
Evaluation of the protein fold of the pocr mutants
Far UV CD analysis of each of the four pocr mutants was
performed along with Ocr for comparison (Supplementary
Figure S3). The spectra were analysed using the Dichroweb
online secondary structure deconvolution program (38).
The CDSSTRmethod gave a -helical content of∼60% for
Ocr, which is in good agreement with the crystal structure.
Similar values (±2%) were obtained for each of the pocr
mutants, indicating that the absence of approximately half
of the acidic residues present on Ocr has no significant ef-
fect on its secondary structure. Thus, it appears that many
of the acidic residues on the wild-type Ocr protein have no
substantial bearing on its overall structural integrity. Wild-
type Ocr is known to exist as a homodimer in solution. Glu-
taraldehyde crosslinking confirmed that the selected pocr
mutants also exist as dimers (Supplementary Figure S4).
The thermal stability of the pocr mutants was assessed us-
ing a fluorescence-based denaturation assay. Wild-type Ocr,
M1.1, M2.1 and M2.8 all gave a similar Tm value of 54–
57◦C under the conditions used in our assay. Intriguingly,
however, mutant M1.9 displayed a Tm of 67◦C, indicating
an enhanced thermal stability (Supplementary Figure S5).
The curious enhancement in thermal stability of M1.9 may
be related to an increase in the distance between discrete
carboxylates on the protein surface, which reduces electro-
static repulsion. Indeed, the closeness of the carboxylates in
Ocr is approximately equal to the Bjerrum length, leading
to electrostatic repulsion energies of the order kBT (39).
Isothermal titration calorimetry
ITC was used to analyse the interaction between M.EcoKI
and each of the four unique pocr proteins. Wild-type Ocr
was used as a positive control. Each injection peak was in-
tegrated and the heat of dilution subtracted. A plot of the
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Figure 3. Cell growth ofE. coliNM1041 (r+) after transformationwith differentmutants from the ISOR library. Top: a partially activemutant (mutant 2.4).
Middle: an inactive mutant (mutant 2.5). Bottom: a toxic mutant (mutant 21+10). From left to right each panel shows growth on LB-agar supplemented
with ampicillin (50 g/ml), with 50 g/ml IPTG and ampicillin, and lastly with 50 g/ml IPTG, 20 g/ml 2AP and ampicillin. Serial dilutions of cultures
were spotted in triplicate in an anticlockwise or clockwise fashion.
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Table 1. In vivo antirestriction and antimodification activity of Ocr and selected pocr mutant proteins
Plasmid
Efficiency of plating on strain transformed
with plasmid
Efficiency of plating after recovery from modifying
strain transformed with plasmid
Vector pTrc99A 5×10−5 1
Ocr 4 1.4×10−4
M2.8 2 2.7×10−4
M2.1 2 1.7×10−4
M1.1 3 2.1×10−4
M1.9 1 1.7×10−4
The titre of phage v.o per millilitre was determined in E. coliNM1261(DE3) (r−m−) and E. coliNM1049(DE3) (r+m+) transformed with either the vector
alone (pTrc99A) or plasmid expressing Ocr or pocr mutant (M2.8, M2.1, M1.1 or M1.9). The ratio of phage per ml in E. coliNM1049(DE3) to phage per
ml in E. coli NM1261(DE3) was calculated to obtain the efficiency of plating (eop). For the antimodification assays, unmodified phage v.o grown on E.
coliNM1057 (r−m+, clpX−) in the presence or absence of Ocr or pocr mutant were recovered and a phage stock generated. The degree of antimodification
was assessed by determining the eop of each phage stock on a restriction-proficient strain (E. coli NM1041 (r+m+, clpX−)), relative to a non-restricting
strain (E. coli NM1057 (r−m+, clpX−)). Errors in the number of plaques where ±20% from full plate assays performed in triplicate.
heat of interaction versus the molar ratio of Ocr dimer to
M.EcoKI was then generated (Supplementary Figure S6).
As found previously (10,13), the interaction between wild-
type Ocr and M.EcoKI was highly exothermic and exhib-
ited essentially stoichiometric binding (one Ocr dimer per
M.EcoKI) within the concentration range used in these ex-
periments (Supplementary Figure S6). However, the bind-
ing of Ocr to M.EcoKI was too strong to allow determi-
nation of the dissociation constant, which has been esti-
mated as ∼50 pM using other methods (10). For the pocr
mutants the enthalpy of interaction with M.EcoKI varied
with each mutant. The pocr mutant proteins M2.1, M2.8
and M1.1 displayed a highly exothermic interaction with
M.EcoKI similar to that observed for wild-type Ocr under
the same experimental conditions. By contrast, the interac-
tion of M1.9 with M.EcoKI showed a markedly reduced
enthalpy of interaction (Supplementary Figure S6).
Nuclease assay
In vitro nuclease assays were performed to analyse the level
of inhibition exerted by the mutated forms of pocr (Fig-
ure 2). Unmethylated pBRsk1, containing a single EcoKI
recognition sequence, was used as substrate. A 10-fold ex-
cess of Ocr/pocr was pre-incubated with EcoKI prior to the
addition of plasmid substrate and cofactors. Linearisation
of the plasmidDNAwas assessed by subjecting the reaction
mixture to agarose gel electrophoresis. Using a molar ratio
of 1:10 of nuclease to antirestriction protein, complete inhi-
bition of EcoKI by Ocr, M2.8 and M2.1 was observed. By
contrast, the pocr mutants M1.1 and M1.9 displayed only
partial inhibition of the endonuclease. The experiment was
then repeated using a reduced molar ratio of 1:5 nuclease
to antirestriction protein. Under these conditions, partial
inhibitory activity was observed for pocr mutant M2.1 as
well asM1.9 andM1.1. However, themutantM2.8 together
with wild-type Ocr retained full inhibitory activity.
Analysis of further mutants from the ISOR libraries
The recovery of only four active protein sequences from
the millions of sequences generated by the ISOR procedure
was disappointing and suggests that the evolutionary path
from pocr to Ocr is difficult. Thus we decided to return to
the first three libraries generated and to select at random a
group of 65 sequences for further analysis using our range
of in vivo techniques (Supplementary Table S3). Eleven of
the group proved to give irreproducible results when grow-
ing onmedia containing 20 g/ml 2AP, sometimes growing
and sometimes not, so these were not analysed further. This
group contained two, seven and twomembers from libraries
1, 2 and 3 respectively.
The remaining 54, made up of 21, 15 and 18 representa-
tives from libraries 1, 2 and 3 respectively, gave reproducible
results in the 2AP assay showing several different behaviors
in a strain expressing HsdR, namely, limited growth in the
presence of IPTG and evenmore limited growth in the pres-
ence of 20 g/ml 2AP (without filamentation––see later),
growth in the presence of IPTG but not when 20 g/ml
2AP was also present and limited growth in the presence of
IPTG and even more limited growth in the presence of 20
g/ml 2AP (with filamentation – see later) (Figure 3). We
term these three situations as Partially Active (PA), Inactive
(IN) and Toxic, respectively. Previously we have found fully
active mutants and three partially active mutants, Mut12,
Mut16 and Ocr/pocr, but the three partially active mutants
were not able to grow at all in the presence of 20 g/ml
2AP (15). These partially active mutants are therefore dis-
tinct from the current PA mutants, which do grow a little
in the presence of 2AP and are therefore listed as PA* in
Supplementary Table S3.
The ISOR mutants in groups PA, IN and Toxic were
tested using the antirestriction and antimodification assays
and this revealed that, apart from one instance, these three
groups possessed no antirestriction or antimodification ac-
tivity (Supplementary Table S3). The mutant 3.11 showed
full antirestriction and antimodification activity (antire-
striction value of 0.37 and antimodification value of 1.9 ×
10−4 for comparison to values in Table 1) despite being clas-
sified as Toxic in the presence of IPTG. Leaky expression in
the absence of IPTG has been found previously to be suf-
ficient for antirestriction and antimodification activity (11)
so this apparently contradictory behaviour of mutant 3.11
can be reconciled. The antirestriction and antimodification
activity of this mutant indicates that the protein is folded.
Microscopy revealed that the IN and Toxic mutants in-
duced filamentation indicative of a deleterious effect on cell
division and suggestive that they are interacting with other
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Figure 4. Microscopy images of E. coli NM1041 (r+) transformed with different mutants from the ISOR library. The top row shows DAPI fluorescence
from stained chromosomes while the bottom row shows phase contrast images of the whole cells. From the left to right the cells are transformed with a
partially active mutant (mutant 2.4), an inactive mutant (mutant 2.5) and a toxic mutant (mutant 21+10).
proteins (Figure 4 and Supplementary Table S3). This oc-
curred in both hsdR− and hsdR+ strains.
Analysis of growth curves for the three main groups of
mutants in hsdR− and hsdR+ strains showed that the PA
mutants grew normally in the absence of HsdR but grew
slowly in its presence, thus indicating that the mutants are
capable of interacting with HsdR even though not suffi-
ciently strongly to inhibit restriction in the antirestriction
assay (Figure 5, Supplementary Table S3). These findings
suggest this group of mutant proteins are folded in vivo. The
IN group of mutants had no effect on the growth curves ir-
respective of whether HsdR was present or not (Figure 5,
Supplementary Table S3). Thus, it is not clear from this ex-
periment whether these mutant proteins are capable of fold-
ing. However, the observation of filamentation (Figure 4)
suggests that they are capable of interacting with other pro-
teins in the cell so they may be folded. In addition, we have
previously found that inactive mutant forms of Ocr can be
purified and are folded (15). Thus, we suggest that at least
some members of the IN group are folded. The mutants in
the Toxic group showing no antiRM activity demonstrated
slowed cell growth in both hsdR− and hsdR+ strains (Figure
5, Supplementary Table S3). This observation indicates that
these mutant proteins are folded and capable of interacting
with HsdR as well as other protein species within the cell.
Taken together, we conclude that all of the PA and Toxic
mutants selected for analysis are folded in vivo. Moreover,
some of these mutant forms of pocr are capable of inter-
acting with the EcoKI Type I enzyme and others can also
interact with alternative proteins to interfere with cell divi-
sion.We also conclude that a non-zero proportion of the IN
mutants are folded.
Amino sequence analyses
Sequence alignments were performed on each group of
ocr/pocr mutant forms, namely Active, PA*, PA, Inactive
and Toxic. The complete alignments for each group of
variants are given in Supplementary Figure S7. Although
it is apparent that sequences associated with non-active
variants of the wild-type Ocr protein tend to have fewer
acidic residues, no obvious straightforward pattern asso-
ciated with the groupings derived by our experimental re-
sults is immediately discernible. A further alignment de-
rived from a BLASTP search of non-redundant protein se-
quences using the wild type Ocr sequence was performed,
Supplementary Figure S8. This alignment revealed that ho-
mologues to Ocr contained very similar patterns and num-
bers of acidic residues to Ocr.
To pull out any trend in the arrangement or number of
negative residues in a givenOcr or pocr variant, a number of
further analyses were performed. Firstly, the number of neg-
ative residues in the complete sequence, in the three sections
mimicking the different parts of the DNA target shown in
Figure 1b, and in the two loops (loops 1 and 2) were deter-
mined for each Ocr and pocr variant, Supplementary Ta-
ble S3. Secondly, the number of sequences in each group
containing a given number of negative residues in a partic-
ular region was plotted on a bar chart, Figure 6. Lastly, the
number of negative charges for each Ocr or pocr variant in
each regionwas plotted against the total number of negative
charges in the Ocr or pocr variant, Figure 7.
The bar charts, Figure 6, split the various groups of activ-
ities with it being particularly clear that an active ocr variant
requires at least 14 negative residues in total and that these
should be located in the ‘orange’ region shown in Figure
1b. The other groups of activities tend to overlap with each
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Figure 5. Growth curves of E. coli transformed with different mutants
from the ISOR library. Top: a partially activemutant (mutant 2.4).Middle:
an inactive mutant (mutant 2.5). Bottom: a toxic mutant (mutant 21+10).
E. coli NM1261 (r-) in green is supplemented with 50 g/ml IPTG and in
black is without IPTG. E. coli NM1041 (r+) in red is supplemented with
IPTG and in blue is without IPTG. The E. coli NM1261 curves are offset
from the zero.
other so no further trend is very obvious in these bar charts.
Figure 7 pulls out some further features of the number of
negative residues to be found in each group of activities. To
be active, in addition to at least 14 negative residues in to-
tal, Ocr requires an excess of charges in the orange region
(at least 6 of a possible 9) and no more than average in the
purple region (no >47% of the total). The number of nega-
tive charges in the green region is not too important as long
as it is at least three. The active variants found in the ISOR
library are all close to the boundary between inactivity and
activity while those engineered previously (15) are closer
to the wild type Ocr charge composition as expected from
their biased construction method. This biased construction
method also places some inactive variants (Mut10, Mut11
and Mut13) and the PA* variants (Mut3, Mut12, Mut16
and ocr/pocr) within the space occupied by the active Ocr
variants.
The unusual pocr variant, 3.11, which shows antiRM ac-
tivity but also toxicity lies within the group of active vari-
ants isolated from the ISOR library. A range of Inactive, PA
and Toxic variants from the ISOR library possess 13 nega-
tive charges and lie just below the boundary for Ocr activity
(MM6, C2, 21+8, 2.4, DG3 and DG12). These particular
mutant forms of Ocr show fewer than expected charges in
the green region, more than expected in the orange region
and no correlation in the purple region.
DISCUSSION
The DNA mimicry of Ocr, which is crucial for its ability
to act as an antirestriction protein, comprises two main
features; namely, shape and charge. Here, we have inves-
tigated the charge mimicry of Ocr. The Ocr protein is re-
plete with acidic residues, which generate a highly negatively
charged surface that mimics the phosphate backbone of the
DNA duplex. ITC data for the interaction between Ocr and
M.EcoKI under different salt conditions is consistent with
the idea that the binding is driven, at least to a large extent,
by electrostatics (13). Previously, we have investigated the
charge mimicry by removing charge from the wild type Ocr
protein focussing either on one or two residues at a time (14)
or on contiguous blocks of charge (15) and our results indi-
cated that loops 1 and 2 includedwithin the regionsmimick-
ing the DNA target of the RM enzyme were important for
activity (Figure 1). However, this methodology is strongly
biased by our knowledge of the protein structure. Here, we
have approached the evolution of Ocr from the opposite di-
rection by starting from a gene encoding no acidic residues,
but with the remainder matching Ocr, and then subjecting
the gene to directed evolution until activity was detected. In
this way the two approaches will overlap to reveal at what
point activity appears.
In order to gradually evolve the pocr gene in the desired
fashion, we chose to utilise a modified version of the ISOR
methodology (35,36). We were able to gradually mutate the
pocr gene and select for antirestriction activity after each
round of ISOR. In all, three rounds of mutagenesis were re-
quired before clones showing antirestriction activity could
be detected. Seven individual clones (M1.1, M1.4, M1.7,
M1.9, M2.1, M2.8 and M2.11) were selected but only four,
M1.1, M1.9, M2.1 and M2.8 were unique. These protein
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Figure 6. Bar charts showing the number of sequences analysed in each group of activities having a particular number of negative charges in various
structural regions of Ocr. The bars are coloured as follows: Active (red), Inactive (IN, green), partially active (PA, blue), partially active from reference 15
(PA*, cyan) and toxic (magenta).
sequences were folded and active in a range of in vivo and
in vitro experiments. Thus, the evolutionary process to in-
troduce negative charges into pocr had generated mutants
of Ocr that overlap with those made by removing negative
charges from thewild typeOcr. The effectiveness of the pocr
proteins as antirestriction proteins follows the order: wild
type Ocr = M2.8 > M2.1 > M1.1 > M1.9.
A sequence comparison of these pocr clones along with
that of Ocr is shown in Figure 8. The four pocr mutant se-
quences display some striking similarities to one another.
Firstly, the number of acidic residues in each pocr mutant
is similar i.e., 14, 16, 16 and 17 for M1.9, M1.1, M2.1 and
M2.8, respectively. At least 50% of the acidic residues intro-
duced into the four pocr clones are clustered in the two loop
regions of Ocr (Figures 1a and Figure 8). Sequence align-
ments reveal M2.1 contains all seven acidic residues within
loop 2, and mutant M2.8 includes all five acidic residues in
loop 1 (Figure 8). These findings support the proposal that
acidic residues in the two loop regions (particularly loop 2)
are important for antirestriction activity as previously sug-
gested on the basis of site directed mutagenesis studies (15).
If from these results and the structural features highlighted
in Figure 1, we propose that the acidic residues in the two
loops or alternatively, the green and orange regions identi-
fied as mimicking the sequence-specific and the central non-
specific parts of the Type I RM enzyme target sequence, are
particularly significant for the interaction of Ocr with Type
I RM enzymes, then one might anticipate that these amino
acids would bewell conserved. A sequence alignment ofOcr
homologues reveals that there is indeed a very high degree
of conservation of acidic residues in these loops and DNA-
mimicking regions (Supplementary Figure S8).
However, it must be borne in mind that pocr itself does
not appear to fold into a stable protein. Hence, some of
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Figure 7. Plots of the number of negative charges in the three regions defined in Figure 1b against the total number of negative charges in the whole
sequence for each Ocr and pocr variant. The points are coloured as follows: Active (red), Inactive (green), Partially Active (blue), Partially Active from
reference 15 (PA*, cyan), Toxic (magenta), Toxic mutant 3.11 (olive) and pocr (black).Various mutants are highlighted including the MutX mutants from
reference 15. The vertical dashed line indicates a total negative charge of −14 while the other dashed line joins pocr to wild type Ocr.
the amino acid substitutions introduced into selected pocr
mutants during the process of directed evolution will be
structurally important. Initially, we focussed on evolving
antirestriction activity, but only a small number of posi-
tive mutants were isolated. To fill in the gap from inactive
pocr to active mutants M1.1, M1.9, M2.1 and M2.8, we re-
examined the three libraries produced in the first rounds of
ISOR. A survey of a range of pocr mutants from these li-
braries revealed several behaviours falling short of full an-
tirestriction activity, which were grouped as Inactive, Toxic
or partially active (PA) (Figures 3-5, Supplementary Table
S3). Given thatmost of thesemutant forms of pocr elicited a
significant effect on the growth characteristics of their hosts,
it is clear the proteins are being expressed and are able to
fold. The analysis of fully active pocr and Ocr mutants and
homologues proteins indicates that the amount of charge
in the regions mimicking the DNA target sequence and the
non-specific central part of the target (the green and or-
ange regions of Figure 1b, respectively) and the overall total
charge are important for activity, Figures 6 and 7.
Figure 7 shows plots of all of our mutants derived from
Ocr (15) and from pocr using axes for total negative charge
and total negative charge in various defined regions of
the structure. These plots reveal a continuum of mutants
stretching from the inactive pocr to the fully active Ocr. The
three groups of mutants, inactive, PA and toxic, lacking an-
tirestriction and antimodification activity all overlap with
each other indicating that the fine details of the location of
the negative charges can have a large effect on the behaviour
of the polypeptide. These three groups are separate from the
active mutants.
Of particular interest is the region at which the four ac-
tive pocr mutants found in this work appear. In the mid-
dle of this group lies a very unusual pocr mutant, 3.11,
which showed full antirestriction and antimodification ac-
tivity but whose overexpression resulted in toxicity and cell
death. Just next to this active group andmutant 3.11 lie sev-
eral Inactive, PA and Toxic variants. A sequence alignment
of these variants with 3.11 and the active Ocr sequences is
given in Figure 8. Crucially all these inactive, PA or toxic
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Figure 8. Sequence alignment of the active pocr clones selected from the third round of directed evolution and those found to be inactive, toxic or partially
active but being very close in charge distribution to active mutants. Acidic residues are highlighted by red shading. The secondary structure elements of
Ocr (helix = h, loop = dash) and the regions corresponding to different parts of the DNA target (highlighted in green, orange and purple) as shown in
Figure 1b are also given.
Figure 9. The structural model of the complex ofM.EcoKI (green) bound to Ocr (light brown, 26) focussing on the possible hydrogen bonding interactions
in the Ocr structure between E88 (cyan) in Helix D with the amide groups of the main peptide chain of Loop 2 (PDB:2Y7C). The residues and main chains
are displayed using sticks and the hydrogen bonds using black dotted lines. The bond lengths are all ∼3 A˚.
mutants are lacking negative charges onHelix B in the green
region of the structure and lack aspartate at position 88 (ex-
cept DG12). This E88 location is conserved in active forms
of the mutants and in naturally occurring relatives of Ocr
(Figure 8, Supplementary Figure S8 and Supplementary
Table S3). Thus, based on sequence analysis; (i) activity re-
quires sufficient negative charge in the green and orange re-
gions, and (ii) toxicity is avoided by maintaining aspartate
at position 88. The avoidance of toxicity would also provide
the evolutionary pressure to move away from this small re-
gion of the plots in Figure 7 by acquiring further negative
charge.
Examination of the crystallographic structure of Ocr
shows that E88, which is part of Helix D, can potentially
make several hydrogen bonds to residues in loop 2 (Figure
9). If the ability to make these hydrogen bonds is removed,
as in the toxic mutant 3.11, then loop 2 will be much more
flexible. This may allow loop 2 to form unwanted interac-
tions with proteins involved in cell division and hence cause
growth problems for the host cell. It is worth recalling that
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Ocr has been shown to bind to the RNA polymerase in E.
coli so the ability to form extraneous interactions is not un-
precedented (40).
The number of potential variants of ocr containing 34
possible negative or neutral amino acids is 234 or 1.7 × 1010
and we screened ∼1.2 × 106 of this number. In our screen
we found only four unique active sequences or 0.0003% of
the 1.2 × 106 sequences screened. If this 0.0003% of active
sequences is true for the 234 variants then we expect the
234 variants to include 0.0003% of 234 active sequences or
∼216 active sequences indicating that an activeOcr sequence
should contain about 16 negative charges. This is approx-
imately the same as found experimentally. Obviously Ocr
has not really evolved from pocr but will have started from
some other location in the plots shown in Figure 7 andmost
probably with an ‘average’ number of negative and positive
side chains (12 of each would be expected rather than the 34
and 6 respectively actually observed per monomer). How-
ever, whatever the evolutionary origins of Ocr, the surfeit of
acidic residues ensures that both modification and restric-
tion are efficiently inhibited and toxicity is avoided.
In summary, a detailed examination of our data shows
that to obtain an active antirestriction and antimodification
Ocr protein capable of being expressed without deleterious
effects on the host cell one has to achieve several conditions
as follows:
The pI must be 4.5 or less.
The number of negative charges in the orange region must
be at least 6.
In the purple region, there should be no more than 47% of
the total number of negative charges.
The green region should contain at least three negative
charges.
The total number of negative charges on the whole sequence
must be at least 14.
Position 88 must be aspartate to form hydrogen bonds to
loop 2 thereby constraining its conformation and remov-
ing its ability to interact with other proteins in the cell in-
volved in cell division.
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